Siao Derrick, Somsouk Ma
Department of Medicine, Division of Gastroenterology, University of California San Francisco, 513 Parnassus Ave., Rm-357, San Francisco, CA, 94143, USA,
J Gen Intern Med. 2014 Mar;29(3):520-8. doi: 10.1007/s11606-013-2630-y. Epub 2013 Sep 25.
Helicobacter pylori has been causally linked to a number of diseases, including peptic ulcer disease, gastric adenocarcinoma, mucosa-associated lymphoid tissue lymphoma, and dyspepsia. It is the most prevalent bacterial pathogen in humans, and while the overall prevalence in the United States is about 30 %, the distribution is heterogeneous amongst different ethnic groups. Recent immigrants from high prevalence areas such as Korea, Japan, and China bear an increased burden of its disease and complications. There is clear evidence that treatment of H. pylori resolves peptic ulcer disease, and increasing evidence for protection against development of gastric adenocarcinoma. However, H. pylori treatment failure is common and alternative regimens may be necessary. The following case-based review will highlight these issues, including the epidemiology of H. pylori in the immigrant population, an approach to dyspepsia, and the role of H. pylori in gastric adenocarcinoma.
幽门螺杆菌已被证实与多种疾病存在因果关系,包括消化性溃疡病、胃腺癌、黏膜相关淋巴组织淋巴瘤和消化不良。它是人类中最普遍的细菌病原体,在美国,总体患病率约为30%,但在不同种族群体中的分布并不均匀。来自韩国、日本和中国等高流行地区的新移民承受着更高的幽门螺杆菌相关疾病及其并发症负担。有明确证据表明,幽门螺杆菌的治疗可治愈消化性溃疡病,且越来越多的证据表明其对预防胃腺癌的发生有保护作用。然而,幽门螺杆菌治疗失败很常见,可能需要替代方案。以下基于病例的综述将突出这些问题,包括移民人群中幽门螺杆菌的流行病学、消化不良的处理方法以及幽门螺杆菌在胃腺癌中的作用。